Trial Profile
DNA repair gene expression levels in NSCLC patients treated with platinum based chemotherapy: an open label randomized phase II study.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Aug 2011
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Gemcitabine (Primary)
- Indications Non-small cell lung cancer
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms GENE-REPAIR
- 03 Aug 2011 New trial record